Pharmaceutical Representative
Pharmaceutical Representative recently asked members of its Reader Advisory Panel to describe their new year's resolutions. If you're thinking about making a resolution, these examples may give you some good ideas.
All News
Advertisement
Pharmaceutical Representative
FDA Commissioner David Kessler, M.D., is leaving after six years at the agency
Advertisement
Pharmaceutical Representative
Pharmaceutical Representative recently asked industry experts to predict the future. The following are their responses about the coming year.
Pharmaceutical Representative
Psychiatrists have developed new clinical guidelines for treating bipolar disorder and schizophrenia.
Pharmaceutical Executive
We asked top intellectual property lawyers about what the Supreme Courts decision will mean for pharma and biotech companies. Here is our forward-looking analysis of their comments.
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
2
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
3
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
4
The Evolving Relationship Between FDA and Biotech
5